Skip to main content

Closed

DMAC: DiaMedica Therapeutics Inc. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

36thpctl

Volume

0.45×avg

Market Cap

341.62MUSD

P/E Ratio

-8.9TTM

Div Yield

-ann

DiaMedica Therapeutics Inc.

DMACNASDAQ Capital Market·USD·Closed

DiaMedica Therapeutics Inc.

DMACNASDAQ·USD·Closed

$6.34

−2.61%

$6.34

−$0.17 (2.61%)

52W Range

36thpctl

Volume

0.45×avg

Mkt Cap

341.62MUSD

P/E

-8.9TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings